Microbial contamination of home nebulizers in children with cystic fibrosis and clinical implication on the number of pulmonary exacerbations.
Contamination
Cystic fibrosis
Exacerbation
Microorganism
Nebulizer
Journal
BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563
Informations de publication
Date de publication:
06 Feb 2020
06 Feb 2020
Historique:
received:
20
01
2019
accepted:
23
01
2020
entrez:
8
2
2020
pubmed:
8
2
2020
medline:
28
11
2020
Statut:
epublish
Résumé
Early detection of pulmonary contamination in children with cystic fibrosis (CF) is essential since these children are vulnerable to Pseudomonas aeruginosa (P. aeruginosa) colonization. In Iran, home nebulization of antibiotics is a widespread practice in treatment for patients with CF and, to the best our knowledge, no bacteriological surveys have been conducted till date in this regard. This observational, cross sectional study was conducted on 61 children with CF at Mofid Children's Hospital, Tehran, from September 2017 to march 2018. The swab sampling was performed from 61 home nebulizers used by children diagnosed with CF. Contemporaneous sputum sample or deep nasopharyngeal swab was taken from each patient for bacterial and fungal testing. Medical records of the patients were reviewed and the number of exacerbations were recorded over the last 12 months prior to the study enrollment. The results of study showed that, 43 (70.5%) nebulizers were contaminated; 31 (50.8%) mouthpieces, 21 (34.4%) reservoirs, and 11 (18%) connecting tubes. The most common organism to be isolated was P. aeruginosa and was recovered from 19 (31%) nebulizers, 16 of them belonged to patients chronically colonized with P. aeruginosa. The remaining three had at least one positive sputum culture for P. aeruginosa in the past 1 year before the study. There was a significant increase in the number of CF exacerbations with an average number of exacerbation being 1.5 ± 1(SD) over last 12 months in children who had pathogenic organisms recovered from their home nebulizers compared with 0.4 ± 0.7(SD) exacerbations per year in whom non-pathogenic organisms were isolated from their nebulizers (P < 0.001). The majority of domiciliary nebulizers used by children with CF were contaminated with microorganisms indicating that the nebulizers may serve as potential reservoirs of pathogens for the patients' lung. Perpetuating colonization is a possible concern in the ones recently colonized with P. aeruginosa and, therefore, decontamination of nebulizer requires more attention to prevent ongoing infection. The negative impact of contamination of nebulizer on CF exacerbation requires serious attention and further investigations.
Sections du résumé
BACKGROUND
BACKGROUND
Early detection of pulmonary contamination in children with cystic fibrosis (CF) is essential since these children are vulnerable to Pseudomonas aeruginosa (P. aeruginosa) colonization. In Iran, home nebulization of antibiotics is a widespread practice in treatment for patients with CF and, to the best our knowledge, no bacteriological surveys have been conducted till date in this regard.
METHOD
METHODS
This observational, cross sectional study was conducted on 61 children with CF at Mofid Children's Hospital, Tehran, from September 2017 to march 2018. The swab sampling was performed from 61 home nebulizers used by children diagnosed with CF. Contemporaneous sputum sample or deep nasopharyngeal swab was taken from each patient for bacterial and fungal testing. Medical records of the patients were reviewed and the number of exacerbations were recorded over the last 12 months prior to the study enrollment.
RESULTS
RESULTS
The results of study showed that, 43 (70.5%) nebulizers were contaminated; 31 (50.8%) mouthpieces, 21 (34.4%) reservoirs, and 11 (18%) connecting tubes. The most common organism to be isolated was P. aeruginosa and was recovered from 19 (31%) nebulizers, 16 of them belonged to patients chronically colonized with P. aeruginosa. The remaining three had at least one positive sputum culture for P. aeruginosa in the past 1 year before the study. There was a significant increase in the number of CF exacerbations with an average number of exacerbation being 1.5 ± 1(SD) over last 12 months in children who had pathogenic organisms recovered from their home nebulizers compared with 0.4 ± 0.7(SD) exacerbations per year in whom non-pathogenic organisms were isolated from their nebulizers (P < 0.001).
CONCLUSION
CONCLUSIONS
The majority of domiciliary nebulizers used by children with CF were contaminated with microorganisms indicating that the nebulizers may serve as potential reservoirs of pathogens for the patients' lung. Perpetuating colonization is a possible concern in the ones recently colonized with P. aeruginosa and, therefore, decontamination of nebulizer requires more attention to prevent ongoing infection. The negative impact of contamination of nebulizer on CF exacerbation requires serious attention and further investigations.
Identifiants
pubmed: 32028925
doi: 10.1186/s12890-020-1059-4
pii: 10.1186/s12890-020-1059-4
pmc: PMC7006379
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
33Références
Presse Med. 2017 Jun;46(6 Pt 2):e165-e175
pubmed: 28554723
Int J Pharm. 2011 Mar 15;406(1-2):1-10
pubmed: 21232585
Pediatr Int. 2006 Oct;48(5):454-8
pubmed: 16970782
Am J Infect Control. 2000 Oct;28(5):347-51
pubmed: 11029133
J Cyst Fibros. 2010 Jan;9(1):1-16
pubmed: 19833563
Infect Control Hosp Epidemiol. 2003 May;24(5 Suppl):S6-52
pubmed: 12789902
Annu Rev Med. 2007;58:157-70
pubmed: 17217330
BMC Pulm Med. 2016 Dec 5;16(1):174
pubmed: 27919253
BMC Pulm Med. 2017 Dec 11;17(1):188
pubmed: 29228933
Child Care Health Dev. 2007 Jul;33(4):491-5
pubmed: 17584406
Iran J Pediatr. 2013 Apr;23(2):212-5
pubmed: 23724185
J Bras Pneumol. 2011 May-Jun;37(3):341-7
pubmed: 21755189
J Cyst Fibros. 2008 Sep;7(5):359-67
pubmed: 18304896
Lancet. 2003 Feb 22;361(9358):681-9
pubmed: 12606185
J Cyst Fibros. 2016 Mar;15(2):147-57
pubmed: 26454351
Braz J Infect Dis. 2012 Mar-Apr;16(2):122-8
pubmed: 22552452
Eur J Clin Microbiol Infect Dis. 2013 Oct;32(10):1231-52
pubmed: 23619573
J Bras Pneumol. 2014 Mar-Apr;40(2):119-27
pubmed: 24831395
J Hosp Infect. 2001 Nov;49(3):229-30
pubmed: 11716644
J Clin Microbiol. 1996 Mar;34(3):584-7
pubmed: 8904419
J Pediatr. 1987 Aug;111(2):212-6
pubmed: 3612391
Am J Respir Crit Care Med. 2003 Oct 15;168(8):918-51
pubmed: 14555458
Ann Am Thorac Soc. 2015 Nov;12 Suppl 2:S200-6
pubmed: 26595740